What the New 2025 Lupus Treatment Guideline Means for You

If you live with systemic lupus erythematosus (SLE), you already know this condition can affect your life in many ways — from the fatigue and brain fog you feel day to day to the serious organ inflammation that can develop over time. The American College of Rheumatology (ACR) has recently released updated a lupus treatment guideline, along with a companion report highlighting what matters most to real patients in their care.

Together, these documents offer a clearer, more patient-centered roadmap for managing lupus today.

Understanding the 2025 ACR Lupus Treatment Guidelines

ACR stands for the American College of Rheumatology, which is basically the go-to organization for doctors who treat diseases like lupus, arthritis, and other autoimmune conditions. Every few years, they publish clinical guidelines—these are expert-backed recommendations that help doctors decide the best ways to diagnose, treat, and manage these complex diseases. Think of ACR guidelines like a GPS for healthcare providers. They don’t tell doctors what they must do, but they offer a trusted roadmap based on the latest research, expert opinion, and patient input. The goal is to make sure care is safe, effective, and consistent, no matter where you live or who your doctor is.

These guidelines cover topics such as which tests to run and when, which treatments are recommended (and which to avoid), how to manage symptoms and improve quality of life, and how to involve patients in decision-making.

What New ACR 2025 SLE Guideline Means for Patients Living With Systemic Lupus Erythematosus

These updated guidelines reflect a major step toward more personalized, equitable, and patient-centered lupus treatment and care. They recognize not just what the research says, but what you experience living with lupus every day — the challenges, the fears, and the goals that shape how you want to be treated. 

Hear from Rheumatology Experts

We met up with Ashira Blazer, MD, MSCI at ACR 2025 to hear her perspective on how the ACR lupus treatment guideline changes the course of lupus. Dr. Blazer is a rheumatologist and assistant professor of medicine and co-director of the Lupus Center at the University of Maryland in Baltimore. Listen to her interview here.

Strong vs Conditional Treatment Recommendations in the SLE Guideline

In the ACR lupus guideline, recommendations are labeled as strong or conditional to help patients understand how confident experts are about a particular treatment.

• A strong recommendation means there is clear evidence that the benefits outweigh the risks for most people with lupus, so it’s generally considered the best option unless you have a specific medical reason not to use it — for example, the strong recommendation that nearly all patients take hydroxychloroquine.
• A conditional recommendation means the treatment may be helpful for many people, but the best choice can depend on your symptoms, preferences, lifestyle, and how you tolerate medications. Conditional recommendations highlight the importance of shared decision-making between you and your doctor.
• The lupus treatment guideline also includes good practice statements, which reflect widely accepted expert advice even when research is limited, such as regularly monitoring for heart, bone, or mental health issues. Together, these categories help personalize lupus care while making treatment decisions more transparent and patient-centered. 

What Do These Lupus Treatment Guideline Recommendations Mean?

In 2024, we spoke with Jeffrey Curtis, MD, MS, MPH, Executive Director at the Foundation for Advancing Science, Technology, Education and Research, who explains the difference between strong or conditional recommendations:

“The ACR guideline presents recommendations that are either strong or conditional. A conditional recommendation means that some patients might think this is a good idea or that it’s suitable for them. But for others, it might not be the best choice and patient preference, and someone’s own medical situation and circumstances have a large influence on the recommendations.”

ACR guidelines label each recommendation as either strong or conditional. A strong recommendation means most patients should follow it—it’s backed by solid evidence and applies broadly. On the other hand, a conditional recommendation depends more on individual circumstances and preferences; what works well for one person might not be the best fit for another.

The Big Picture: What Are the Goals of Lupus Treatment?

According to the new guidelines, lupus care should focus on these major goals:

• Controlling inflammation and keeping lupus quiet (remission or low disease activity)
• Preventing long-term organ damage by addressing both general lupus management and organ-specific manifestations, including skin, joints, hematologic, and neuropsychiatric involvement. This ensures that treatment strategies are tailored not only to overall disease control but also to the unique challenges of different organ systems.
• Highlighting the importance of preventive strategies that include vaccination, infection screening, bone health monitoring, cancer screening, and reproductive planning.
• Reducing medication side effects — especially from steroids

These goals aren’t new, but the updated guidance puts a stronger emphasis on doing all of this with patients, using shared decision-making to choose the treatments that fit best with your symptoms, your lifestyle, and your values.

The Therapies People with Lupus Should Know About

Hydroxychloroquine Benefit for Lupus Outcomes

Hydroxychloroquine (HCQ) remains the cornerstone of lupus treatment. Experts strongly recommend that nearly all people with lupus take HCQ long-term unless there’s a medical reason not to.
HCQ helps reduce flares, protect organs, and improve long-term outcomes. 

Steroids Should Be Used Carefully

Steroids (like prednisone) can be lifesaving during flares, but long-term use comes with many side effects.
The guidelines recommend:

• Using steroids only when truly needed
• Tapering to 5 mg per day or less within six months whenever possible
• Switching to other medications if you can’t get your steroid dose down

 Earlier Use of Immunosuppressants and Biologics

Instead of waiting to see if symptoms get worse, doctors are encouraged to introduce steroid-sparing medications earlier. These include:

• Methotrexate
• Mycophenolate
• Azathioprine
• Biologic medicines like belimumab or anifrolumab

These medications help control lupus inflammation, reduce flares, and protect organs — all while helping you avoid long-term steroid use.